10 XP   0   0   5

Vaxxinity Inc
Buy, Hold or Sell?

Let's analyze Vaxxinity together

I guess you are interested in Vaxxinity Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Vaxxinity Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Vaxxinity Inc

I send you an email if I find something interesting about Vaxxinity Inc.

Quick analysis of Vaxxinity (30 sec.)










What can you expect buying and holding a share of Vaxxinity? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
20.0%

What is your share worth?

Current worth
$0.11
Expected worth in 1 year
$-1.44
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
$-1.55
Return On Investment
-500.3%

For what price can you sell your share?

Current Price per Share
$0.31
Expected price per share
$0.077 - $0.5632
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

1. Valuation of Vaxxinity (5 min.)




Live pricePrice per Share (EOD)

$0.31

Intrinsic Value Per Share

$-6.04 - $-7.12

Total Value Per Share

$-5.93 - $-7.01

2. Growth of Vaxxinity (5 min.)




Is Vaxxinity growing?

Current yearPrevious yearGrowGrow %
How rich?$13.4m$62.1m-$48.7m-363.7%

How much money is Vaxxinity making?

Current yearPrevious yearGrowGrow %
Making money-$56.9m-$75.2m$18.2m32.1%
Net Profit Margin0.0%7,521,000.0%--

How much money comes from the company's main activities?

3. Financial Health of Vaxxinity (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

What can you expect buying and holding a share of Vaxxinity? (5 min.)

Welcome investor! Vaxxinity's management wants to use your money to grow the business. In return you get a share of Vaxxinity.

What can you expect buying and holding a share of Vaxxinity?

First you should know what it really means to hold a share of Vaxxinity. And how you can make/lose money.

Speculation

The Price per Share of Vaxxinity is $0.31. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Vaxxinity.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Vaxxinity, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.11. Based on the TTM, the Book Value Change Per Share is $-0.39 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.53 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Vaxxinity.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.45-145.2%-0.45-145.2%-0.60-192.7%-0.51-166.0%-0.51-166.0%
Usd Book Value Change Per Share-0.39-125.1%-0.39-125.1%-0.53-171.6%0.026.8%0.026.8%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.1030.8%0.1030.8%
Usd Total Gains Per Share-0.39-125.1%-0.39-125.1%-0.53-171.6%0.1237.6%0.1237.6%
Usd Price Per Share0.85-0.85-1.40-1.57-1.57-
Price to Earnings Ratio-1.89--1.89--2.34--1.87--1.87-
Price-to-Total Gains Ratio-2.19--2.19--2.63--0.52--0.52-
Price to Book Ratio8.02-8.02-2.84-3.26-3.26-
Price-to-Total Gains Ratio-2.19--2.19--2.63--0.52--0.52-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.31
Number of shares3225
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.10
Usd Book Value Change Per Share-0.390.02
Usd Total Gains Per Share-0.390.12
Gains per Quarter (3225 shares)-1,250.38375.89
Gains per Year (3225 shares)-5,001.521,503.56
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-5002-501212302731494
20-10003-1001424605472998
30-15005-1501636908204502
40-20006-20018492010946006
50-25008-25020615113677510
60-30009-30022738116419014
70-35011-350248611191410518
80-40012-400269841218812022
90-45014-4502811071246113526
100-50015-5003012301273515030

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.05.00.00.0%0.05.00.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%1.04.00.020.0%1.04.00.020.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%1.00.04.020.0%1.00.04.020.0%1.00.04.020.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%2.03.00.040.0%2.03.00.040.0%
3rd party ad coffee SUPPORTERis ad-free.

Fundamentals of Vaxxinity

About Vaxxinity Inc

Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology, cardiovascular diseases, and coronaviruses in the United States. Its product pipeline comprises UB-311, which is in phase 2 clinical trial that targets toxic forms of aggregated amyloid-b in the brain to fight alzheimer's disease; UB-312, which is in phase 1 clinical trial that targets toxic forms of aggregated a-synuclein in the brain to fight parkinson's disease and other synucleinopathies, such as Lewy body dementia and multiple system atrophy; and VXX-301, which is in preclinical trial, an anti-tau product candidate for various neurodegenerative conditions, including alzheimer's disease, traumatic brain injury, and chronic traumatic encephalopathy. It also develops VXX-401, which is phase 1 clinical trial that targets proprotein convertase subtilisin/kexin type 9 serine protease to lower low-density lipoprotein cholesterol and reduce the risk of cardiac events; UB-313 that targets calcitonin gene-related peptide to fight migraines; and UB-612, neutralizes the SARS-CoV-2 virus and is in phase 3 clinical trial. The company was incorporated in 2021 and is headquartered in Merritt Island, Florida.

Fundamental data was last updated by Penke on 2024-07-03 13:26:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just not able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

1.1. Profitability of Vaxxinity Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Vaxxinity earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Vaxxinity to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Vaxxinity Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY7,521,000.0%-7,521,000.0%
TTM-5Y1,461,107.0%-1,461,107.0%
5Y1,461,107.0%10Y1,461,107.0%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--168.0%+168.0%
TTM--209.9%+209.9%
YOY7,521,000.0%-242.3%+7,521,242.3%
5Y1,461,107.0%-401.7%+1,461,508.7%
10Y1,461,107.0%-532.2%+1,461,639.2%
1.1.2. Return on Assets

Shows how efficient Vaxxinity is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Vaxxinity to the Biotechnology industry mean.
  • -128.4% Return on Assets means that Vaxxinity generated $-1.28 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Vaxxinity Inc:

  • The MRQ is -128.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -128.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-128.4%TTM-128.4%0.0%
TTM-128.4%YOY-70.7%-57.7%
TTM-128.4%5Y-248.8%+120.4%
5Y-248.8%10Y-248.8%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-128.4%-11.9%-116.5%
TTM-128.4%-11.9%-116.5%
YOY-70.7%-11.3%-59.4%
5Y-248.8%-13.5%-235.3%
10Y-248.8%-14.9%-233.9%
1.1.3. Return on Equity

Shows how efficient Vaxxinity is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Vaxxinity to the Biotechnology industry mean.
  • -424.6% Return on Equity means Vaxxinity generated $-4.25 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Vaxxinity Inc:

  • The MRQ is -424.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -424.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-424.6%TTM-424.6%0.0%
TTM-424.6%YOY-121.0%-303.6%
TTM-424.6%5Y-130.6%-294.0%
5Y-130.6%10Y-130.6%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-424.6%-14.2%-410.4%
TTM-424.6%-15.7%-408.9%
YOY-121.0%-14.3%-106.7%
5Y-130.6%-19.2%-111.4%
10Y-130.6%-19.7%-110.9%
3rd party ad coffee SUPPORTERis ad-free.

1.2. Operating Efficiency of Vaxxinity Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Vaxxinity is operating .

  • Measures how much profit Vaxxinity makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Vaxxinity to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Vaxxinity Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY7,597,900.0%-7,597,900.0%
TTM-5Y1,480,519.3%-1,480,519.3%
5Y1,480,519.3%10Y1,480,519.3%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--354.6%+354.6%
TTM--225.9%+225.9%
YOY7,597,900.0%-252.2%+7,598,152.2%
5Y1,480,519.3%-428.3%+1,480,947.6%
10Y1,480,519.3%-531.1%+1,481,050.4%
1.2.2. Operating Ratio

Measures how efficient Vaxxinity is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Vaxxinity Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-77,663.000+77,663.000
TTM-5Y-15,141.593+15,141.593
5Y-15,141.59310Y-15,141.5930.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.004-3.004
TTM-3.332-3.332
YOY-77,663.0003.502-77,666.502
5Y-15,141.5935.271-15,146.864
10Y-15,141.5936.915-15,148.508
3rd party ad coffee SUPPORTERis ad-free.

1.3. Liquidity of Vaxxinity Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Vaxxinity is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.89 means the company has $1.89 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Vaxxinity Inc:

  • The MRQ is 1.888. The company is able to pay all its short-term debts. +1
  • The TTM is 1.888. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.888TTM1.8880.000
TTM1.888YOY3.034-1.147
TTM1.8885Y2.312-0.424
5Y2.31210Y2.3120.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8883.767-1.879
TTM1.8884.000-2.112
YOY3.0344.905-1.871
5Y2.3125.883-3.571
10Y2.3126.286-3.974
1.3.2. Quick Ratio

Measures if Vaxxinity is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Vaxxinity to the Biotechnology industry mean.
  • A Quick Ratio of 3.20 means the company can pay off $3.20 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Vaxxinity Inc:

  • The MRQ is 3.202. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.202. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.202TTM3.2020.000
TTM3.202YOY4.544-1.342
TTM3.2025Y2.790+0.413
5Y2.79010Y2.7900.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.2023.054+0.148
TTM3.2023.506-0.304
YOY4.5444.756-0.212
5Y2.7905.757-2.967
10Y2.7906.338-3.548
3rd party ad coffee SUPPORTERis ad-free.

1.4. Solvency of Vaxxinity Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Vaxxinity assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Vaxxinity to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.70 means that Vaxxinity assets are financed with 69.8% credit (debt) and the remaining percentage (100% - 69.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Vaxxinity Inc:

  • The MRQ is 0.698. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.698. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.698TTM0.6980.000
TTM0.698YOY0.416+0.282
TTM0.6985Y7.100-6.402
5Y7.10010Y7.1000.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6980.330+0.368
TTM0.6980.342+0.356
YOY0.4160.287+0.129
5Y7.1000.368+6.732
10Y7.1000.382+6.718
1.4.2. Debt to Equity Ratio

Measures if Vaxxinity is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Vaxxinity to the Biotechnology industry mean.
  • A Debt to Equity ratio of 230.8% means that company has $2.31 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Vaxxinity Inc:

  • The MRQ is 2.308. The company is just not able to pay all its debts with equity.
  • The TTM is 2.308. The company is just not able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ2.308TTM2.3080.000
TTM2.308YOY0.711+1.596
TTM2.3085Y0.663+1.645
5Y0.66310Y0.6630.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.3080.365+1.943
TTM2.3080.415+1.893
YOY0.7110.370+0.341
5Y0.6630.443+0.220
10Y0.6630.476+0.187
3rd party ad coffee SUPPORTERis ad-free.

2. Market Valuation of Vaxxinity Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Vaxxinity generates.

  • Above 15 is considered overpriced but always compare Vaxxinity to the Biotechnology industry mean.
  • A PE ratio of -1.89 means the investor is paying $-1.89 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Vaxxinity Inc:

  • The EOD is -0.689. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.889. Based on the earnings, the company is expensive. -2
  • The TTM is -1.889. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.689MRQ-1.889+1.200
MRQ-1.889TTM-1.8890.000
TTM-1.889YOY-2.344+0.455
TTM-1.8895Y-1.872-0.017
5Y-1.87210Y-1.8720.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.689-2.341+1.652
MRQ-1.889-2.997+1.108
TTM-1.889-2.882+0.993
YOY-2.344-3.553+1.209
5Y-1.872-6.262+4.390
10Y-1.872-6.288+4.416
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Vaxxinity Inc:

  • The EOD is -0.676. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.853. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.853. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.676MRQ-1.853+1.177
MRQ-1.853TTM-1.8530.000
TTM-1.853YOY-3.051+1.198
TTM-1.8535Y-2.690+0.837
5Y-2.69010Y-2.6900.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.676-2.932+2.256
MRQ-1.853-3.739+1.886
TTM-1.853-3.776+1.923
YOY-3.051-4.917+1.866
5Y-2.690-7.942+5.252
10Y-2.690-8.503+5.813
3rd party ad coffee SUPPORTERis ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Vaxxinity is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 8.02 means the investor is paying $8.02 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Vaxxinity Inc:

  • The EOD is 2.925. Based on the equity, the company is underpriced. +1
  • The MRQ is 8.019. Based on the equity, the company is overpriced. -1
  • The TTM is 8.019. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD2.925MRQ8.019-5.095
MRQ8.019TTM8.0190.000
TTM8.019YOY2.836+5.184
TTM8.0195Y3.265+4.755
5Y3.26510Y3.2650.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.9251.843+1.082
MRQ8.0192.249+5.770
TTM8.0192.301+5.718
YOY2.8362.412+0.424
5Y3.2653.782-0.517
10Y3.2654.212-0.947
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Vaxxinity Inc.

3.1. Institutions holding Vaxxinity Inc

Institutions are holding 10.738% of the shares of Vaxxinity Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Adage Capital Partners Gp LLC2.36690.0053300000000
2023-12-31BlackRock Inc2.14120.000127139161869657.3988
2023-12-31Vanguard Group Inc1.886302390836134510.5658
2023-12-31Prime Movers Lab LLC0.94835.48521201994-14542173-92.3655
2023-12-31Geode Capital Management, LLC0.66430.0001842014122121.4717
2023-12-31State Street Corporation0.63060799273-33200-3.9881
2023-12-31Bank of America Corp0.28270358256-141301-28.2853
2023-12-31Northern Trust Corp0.26390.0001334498-17314-4.9214
2023-12-31Creative Planning Inc0.22490.000528508964432.3123
2023-12-31Morgan Stanley - Brokerage Accounts0.18190230516194045532.0529
2023-12-31Bridgeway Capital Management, LLC0.18080.0042229100154700207.9301
2023-12-31Pathstone Holdings LLC0.12140.00071538461538460
2023-09-30Pathstone Family Office, LLC0.12140.001615384600
2023-09-30SCOGGIN LLC0.11830.084715000000
2023-12-31Bank of New York Mellon Corp0.09520120665-857-0.7052
2023-12-31Charles Schwab Investment Management Inc0.0949012033400
2023-12-31IEQ CAPITAL, LLC0.06570.001283262832620
2024-03-31McAdam, LLC0.06180.00367828100
2023-12-31Barclays PLC0.046105849250698650.4747
2023-12-31Nuveen Asset Management, LLC0.045805802900
Total 10.54245.587313362247-13879223-103.9%

3.2. Funds holding Vaxxinity Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-04-30Vanguard Total Stock Mkt Idx Inv1.17460148927400
2024-04-30iShares Russell 2000 ETF0.78330.0002993061-7896-0.7888
2024-04-30Vanguard Institutional Extnd Mkt Idx Tr0.44340.000156212500
2024-02-29Fidelity Small Cap Index0.30940.001339228500
2024-04-30iShares Russell 2000 Growth ETF0.27810.0004352576-844-0.2388
2024-04-30State St Russell Sm/Mid Cp® Indx NL Cl C0.2620.000133220000
2024-03-31Bridgeway Ultra-Small Company Market0.17090.080721670000
2024-03-31Fidelity Extended Market Index0.16740.000421224500
2024-04-30Vanguard Russell 2000 ETF0.12520.00021587195440.3439
2023-12-31NT R2000 Growth Index Fund - NL0.10090.002912793100
2024-03-31NT R2000 Index Fund - NL0.09690.0012122795960.0782
2023-09-30BlackRock Extended Mkt Composite0.09120.00111156027460.6495
2024-03-31BlackRock Extended Equity Market K0.07870.000599792360.0361
2024-03-31NT R2000 Index Fund - DC - NL - 20.07690.0012975168890.92
2024-04-30Schwab Small Cap Index0.07680.00029741700
2024-04-30iShares Micro-Cap ETF0.0720.001491326-621-0.6754
2024-03-31Northern Trust Russell 2000 Growth Index0.06720.00218520600
2023-12-31NT R2000 Growth Index Fund - L0.06720.002685206-6849-7.4401
2024-03-31BlackRock Russell 2500™ Index F0.06280.000679640330.0415
2024-03-31iShares Russell 2000 Small-Cap Idx Instl0.06270.00117946100
Total 4.56760.09835791077-13866-0.2%

3.3. Insider Transactions

Insiders are holding 50.707% of the shares of Vaxxinity Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-09-08Movers Lab Fund I Lp PrimeSELL250891.67
2023-09-06Movers Lab Fund I Lp PrimeSELL53081.88
3rd party ad coffee SUPPORTERis ad-free.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Vaxxinity Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.388-0.3880%-0.532+37%0.021-1929%0.021-1929%
Book Value Per Share--0.1060.1060%0.494-79%0.108-2%0.108-2%
Current Ratio--1.8881.8880%3.034-38%2.312-18%2.312-18%
Debt To Asset Ratio--0.6980.6980%0.416+68%7.100-90%7.100-90%
Debt To Equity Ratio--2.3082.3080%0.711+224%0.663+248%0.663+248%
Dividend Per Share----0%-0%0.095-100%0.095-100%
Eps---0.450-0.4500%-0.597+33%-0.515+14%-0.515+14%
Free Cash Flow Per Share---0.459-0.4590%-0.459+0%-0.391-15%-0.391-15%
Free Cash Flow To Equity Per Share---0.468-0.4680%-0.460-2%0.043-1183%0.043-1183%
Gross Profit Margin--1.3931.3930%1.000+39%1.079+29%1.079+29%
Intrinsic Value_10Y_max---7.117--------
Intrinsic Value_10Y_min---6.039--------
Intrinsic Value_1Y_max---0.567--------
Intrinsic Value_1Y_min---0.551--------
Intrinsic Value_3Y_max---1.814--------
Intrinsic Value_3Y_min---1.711--------
Intrinsic Value_5Y_max---3.196--------
Intrinsic Value_5Y_min---2.926--------
Market Cap35002410.000-207%107532579.450107532579.4500%176314670.000-39%197459527.462-46%197459527.462-46%
Net Profit Margin----0%75210.000-100%14611.070-100%14611.070-100%
Operating Margin----0%75979.000-100%14805.193-100%14805.193-100%
Operating Ratio----0%-77663.0000%-15141.5930%-15141.5930%
Pb Ratio2.925-174%8.0198.0190%2.836+183%3.265+146%3.265+146%
Pe Ratio-0.689+64%-1.889-1.8890%-2.344+24%-1.872-1%-1.872-1%
Price Per Share0.310-174%0.8500.8500%1.400-39%1.572-46%1.572-46%
Price To Free Cash Flow Ratio-0.676+64%-1.853-1.8530%-3.051+65%-2.690+45%-2.690+45%
Price To Total Gains Ratio-0.800+64%-2.192-2.1920%-2.631+20%-0.522-76%-0.522-76%
Quick Ratio--3.2023.2020%4.544-30%2.790+15%2.790+15%
Return On Assets---1.284-1.2840%-0.707-45%-2.488+94%-2.488+94%
Return On Equity---4.246-4.2460%-1.210-72%-1.306-69%-1.306-69%
Total Gains Per Share---0.388-0.3880%-0.532+37%0.117-433%0.117-433%
Usd Book Value--13409000.00013409000.0000%62177000.000-78%13663600.000-2%13663600.000-2%
Usd Book Value Change Per Share---0.388-0.3880%-0.532+37%0.021-1929%0.021-1929%
Usd Book Value Per Share--0.1060.1060%0.494-79%0.108-2%0.108-2%
Usd Dividend Per Share----0%-0%0.095-100%0.095-100%
Usd Eps---0.450-0.4500%-0.597+33%-0.515+14%-0.515+14%
Usd Free Cash Flow---58041000.000-58041000.0000%-57794000.0000%-49159000.000-15%-49159000.000-15%
Usd Free Cash Flow Per Share---0.459-0.4590%-0.459+0%-0.391-15%-0.391-15%
Usd Free Cash Flow To Equity Per Share---0.468-0.4680%-0.460-2%0.043-1183%0.043-1183%
Usd Market Cap35002410.000-207%107532579.450107532579.4500%176314670.000-39%197459527.462-46%197459527.462-46%
Usd Price Per Share0.310-174%0.8500.8500%1.400-39%1.572-46%1.572-46%
Usd Profit---56934000.000-56934000.0000%-75210000.000+32%-63951000.000+12%-63951000.000+12%
Usd Revenue----0%-1000.0000%124400.000-100%124400.000-100%
Usd Total Gains Per Share---0.388-0.3880%-0.532+37%0.117-433%0.117-433%
 EOD+3 -5MRQTTM+0 -0YOY+12 -205Y+9 -2610Y+9 -26

4.2. Fundamental Score

Let's check the fundamental score of Vaxxinity Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.689
Price to Book Ratio (EOD)Between0-12.925
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than13.202
Current Ratio (MRQ)Greater than11.888
Debt to Asset Ratio (MRQ)Less than10.698
Debt to Equity Ratio (MRQ)Less than12.308
Return on Equity (MRQ)Greater than0.15-4.246
Return on Assets (MRQ)Greater than0.05-1.284
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Vaxxinity Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5065.733
Ma 20Greater thanMa 500.168
Ma 50Greater thanMa 1000.126
Ma 100Greater thanMa 2000.395
OpenGreater thanClose0.270
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets44,353
Total Liabilities30,944
Total Stockholder Equity13,409
 As reported
Total Liabilities 30,944
Total Stockholder Equity+ 13,409
Total Assets = 44,353

Assets

Total Assets44,353
Total Current Assets33,230
Long-term Assets11,123
Total Current Assets
Cash And Cash Equivalents 5,036
Short-term Investments 25,464
Net Receivables 414
Other Current Assets 2,316
Total Current Assets  (as reported)33,230
Total Current Assets  (calculated)33,230
+/-0
Long-term Assets
Property Plant Equipment 11,081
Other Assets 0
Long-term Assets  (as reported)11,123
Long-term Assets  (calculated)11,081
+/- 42

Liabilities & Shareholders' Equity

Total Current Liabilities17,605
Long-term Liabilities13,339
Total Stockholder Equity13,409
Total Current Liabilities
Short-term Debt 1,906
Short Long Term Debt 1,906
Accounts payable 1,783
Other Current Liabilities 13,916
Total Current Liabilities  (as reported)17,605
Total Current Liabilities  (calculated)19,511
+/- 1,906
Long-term Liabilities
Long term Debt 13,262
Long-term Liabilities  (as reported)13,339
Long-term Liabilities  (calculated)13,262
+/- 77
Total Stockholder Equity
Common Stock278
Retained Earnings -361,637
Accumulated Other Comprehensive Income 8
Other Stockholders Equity 374,760
Total Stockholder Equity (as reported)13,409
Total Stockholder Equity (calculated)13,409
+/-0
Other
Capital Stock278
Cash and Short Term Investments 30,500
Common Stock Shares Outstanding 126,509
Liabilities and Stockholders Equity 44,353
Net Debt 10,132
Net Invested Capital 28,577
Net Working Capital 15,625
Property Plant and Equipment Gross 16,948
Short Long Term Debt Total 15,168



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-31
> Total Assets 
1,595
50,141
166,673
106,399
44,353
44,353106,399166,67350,1411,595
   > Total Current Assets 
1,435
35,674
154,129
93,887
33,230
33,23093,887154,12935,6741,435
       Cash And Cash Equivalents 
476
31,143
144,885
33,475
5,036
5,03633,475144,88531,143476
       Short-term Investments 
0
10
869
53,352
25,464
25,46453,352869100
       Net Receivables 
303
387
393
414
414
414414393387303
       Other Current Assets 
656
832
341
522
2,316
2,316522341832656
   > Long-term Assets 
160
14,467
12,544
12,512
11,123
11,12312,51212,54414,467160
       Property Plant Equipment 
160
12,158
12,372
12,512
11,081
11,08112,51212,37212,158160
       Other Assets 
0
2,309
371
0
0
003712,3090
> Total Liabilities 
50,107
137,516
38,054
44,222
30,944
30,94444,22238,054137,51650,107
   > Total Current Liabilities 
19,875
37,224
27,494
30,941
17,605
17,60530,94127,49437,22419,875
       Short-term Debt 
13,185
27,593
376
1,504
1,906
1,9061,50437627,59313,185
       Short Long Term Debt 
13,185
27,593
376
1,504
1,906
1,9061,50437627,59313,185
       Accounts payable 
1,284
1,017
3,192
5,295
1,783
1,7835,2953,1921,0171,284
       Other Current Liabilities 
5,406
8,614
23,926
24,142
13,916
13,91624,14223,9268,6145,406
   > Long-term Liabilities 
30,232
100,292
10,560
13,281
13,339
13,33913,28110,560100,29230,232
       Long term Debt Total 
0
0
10,323
9,933
0
09,93310,32300
       Long term Debt 
1,124
10,699
10,323
9,933
13,262
13,2629,93310,32310,6991,124
       Capital Lease Obligations 
25
13
0
0
0
0001325
       Other Liabilities 
2,264
27,105
237
0
0
0023727,1052,264
       Long-term Liabilities Other 
0
24,335
237
3,348
0
03,34823724,3350
       Deferred Long Term Liability 
0
2,254
0
0
0
0002,2540
> Total Stockholder Equity
-48,512
-87,375
128,619
62,177
13,409
13,40962,177128,619-87,375-48,512
   Common Stock
270
272
278
278
278
278278278272270
   Retained Earnings -361,637-304,703-229,481-92,306-52,349
   Capital Surplus 
0
0
357,822
366,799
0
0366,799357,82200
   Treasury Stock00000
   Other Stockholders Equity 
3,567
4,659
357,822
366,799
374,760
374,760366,799357,8224,6593,567



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-2,234
Gross Profit-2,234-2,234
 
Operating Income (+$)
Gross Profit-2,234
Operating Expense-56,051
Operating Income-58,285-58,285
 
Operating Expense (+$)
Research Development33,665
Selling General Administrative22
Selling And Marketing Expenses22,364
Operating Expense56,05156,051
 
Net Interest Income (+$)
Interest Income2,291
Interest Expense-696
Other Finance Cost-68
Net Interest Income1,527
 
Pretax Income (+$)
Operating Income-58,285
Net Interest Income1,527
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-56,934-59,636
EBIT - interestExpense = -58,981
-56,934
-56,238
Interest Expense696
Earnings Before Interest and Taxes (EBIT)-58,285-56,238
Earnings Before Interest and Taxes (EBITDA)-56,051
 
After tax Income (+$)
Income Before Tax-56,934
Tax Provision-0
Net Income From Continuing Ops-65,998-56,934
Net Income-56,934
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses58,285
Total Other Income/Expenses Net1,351-1,527
 

Technical Analysis of Vaxxinity
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Vaxxinity. The general trend of Vaxxinity is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Vaxxinity's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Vaxxinity Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.5 < 0.56 < 0.5632.

The bearish price targets are: 0.102 > 0.102 > 0.077.

Tweet this
Vaxxinity Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Vaxxinity Inc. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Vaxxinity Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Vaxxinity Inc. The current macd is 0.04307508.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Vaxxinity price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Vaxxinity. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Vaxxinity price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Vaxxinity Inc Daily Moving Average Convergence/Divergence (MACD) ChartVaxxinity Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Vaxxinity Inc. The current adx is 48.15.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Vaxxinity shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Vaxxinity Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Vaxxinity Inc. The current sar is 0.2218.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Vaxxinity Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Vaxxinity Inc. The current rsi is 65.73. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Vaxxinity Inc Daily Relative Strength Index (RSI) ChartVaxxinity Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Vaxxinity Inc. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Vaxxinity price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Vaxxinity Inc Daily Stochastic Oscillator ChartVaxxinity Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Vaxxinity Inc. The current cci is 121.25.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Vaxxinity Inc Daily Commodity Channel Index (CCI) ChartVaxxinity Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Vaxxinity Inc. The current cmo is 36.44.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Vaxxinity Inc Daily Chande Momentum Oscillator (CMO) ChartVaxxinity Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Vaxxinity Inc. The current willr is -44.91725768.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Vaxxinity is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Vaxxinity Inc Daily Williams %R ChartVaxxinity Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Vaxxinity Inc.

Vaxxinity Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Vaxxinity Inc. The current atr is 0.05892875.

Vaxxinity Inc Daily Average True Range (ATR) ChartVaxxinity Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Vaxxinity Inc. The current obv is 19,624,572.

Vaxxinity Inc Daily On-Balance Volume (OBV) ChartVaxxinity Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Vaxxinity Inc. The current mfi is 79.06.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Vaxxinity Inc Daily Money Flow Index (MFI) ChartVaxxinity Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Vaxxinity Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-21MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-01CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-11ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-18RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-05-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-10STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-17SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-20RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-05-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-22MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-05-24RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-06-05WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-06-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-06-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-06-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-06-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-06-18STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-06-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-21MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-06-24STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-06-26BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-06-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-28MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-03STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Vaxxinity Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Vaxxinity Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5065.733
Ma 20Greater thanMa 500.168
Ma 50Greater thanMa 1000.126
Ma 100Greater thanMa 2000.395
OpenGreater thanClose0.270
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Vaxxinity with someone you think should read this too:
  • Are you bullish or bearish on Vaxxinity? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Vaxxinity? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Vaxxinity Inc

I send you an email if I find something interesting about Vaxxinity Inc.


Stay informed about Vaxxinity Inc.

Receive notifications about Vaxxinity Inc in your mailbox!